Development of small-molecule inhibitors of the group I p21-activated kinases, emerging therapeutic targets in cancer.

[1]  Gareth E. Jones,et al.  The emerging importance of group II PAKs. , 2010, The Biochemical journal.

[2]  Jeffrey R. Peterson,et al.  An allosteric kinase inhibitor binds the p21-activated kinase autoregulatory domain covalently , 2009, Molecular Cancer Therapeutics.

[3]  J. R. Peterson,et al.  PAK kinase regulates Rac GTPase and is a potential target in human schwannomas , 2009, Experimental Neurology.

[4]  Da-Qiang Li,et al.  PAK Signaling in Oncogenesis , 2009, Oncogene.

[5]  J. O’Shea,et al.  Selectivity and therapeutic inhibition of kinases: to be or not to be? , 2009, Nature Immunology.

[6]  J. Borg,et al.  Erbin and the NF2 tumor suppressor Merlin cooperatively regulate cell-type-specific activation of PAK2 by TGF-beta. , 2009, Developmental cell.

[7]  Jeffrey Field,et al.  Pak protein kinases and their role in cancer , 2009, Cancer and Metastasis Reviews.

[8]  S. Knapp,et al.  Targeting group II PAKs in cancer and metastasis , 2009, Cancer and Metastasis Reviews.

[9]  J. Chernoff,et al.  Pak1 regulates multiple c-Kit mediated Ras-MAPK gain-in-function phenotypes in Nf1+/- mast cells. , 2008, Blood.

[10]  G. Hutchins,et al.  Nf1-Dependent Tumors Require a Microenvironment Containing Nf1 +/−- and c-kit-Dependent Bone Marrow , 2008, Cell.

[11]  Ronen Marmorstein,et al.  Targeting large kinase active site with rigid, bulky octahedral ruthenium complexes. , 2008, Journal of the American Chemical Society.

[12]  M. Yaffe,et al.  Validation of the p21-activated kinases as targets for inhibition in neurofibromatosis type 2. , 2008, Cancer research.

[13]  U. Knaus,et al.  P21-activated kinase is required for mitotic progression and regulates Plk1 , 2008, Oncogene.

[14]  S. Deacon,et al.  An isoform-selective, small-molecule inhibitor targets the autoregulatory mechanism of p21-activated kinase. , 2008, Chemistry & biology.

[15]  Bonnie F. Sloane,et al.  p21-Activated kinase 1 coordinates aberrant cell survival and pericellular proteolysis in a three-dimensional culture model for premalignant progression of human breast cancer. , 2008, Neoplasia.

[16]  Luis E. Arias-Romero,et al.  A tale of two Paks , 2008, Biology of the cell.

[17]  P. Cohen,et al.  The selectivity of protein kinase inhibitors: a further update. , 2007, The Biochemical journal.

[18]  S. Kulp,et al.  2-Amino-N-{4-[5-(2-phenanthrenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]-phenyl} Acetamide (OSU-03012), a Celecoxib Derivative, Directly Targets p21-Activated Kinase , 2007, Molecular Pharmacology.

[19]  L. Skoog,et al.  Amplification of CCND1 and PAK1 as predictors of recurrence and tamoxifen resistance in postmenopausal breast cancer , 2007, Oncogene.

[20]  C. Matthies,et al.  Actin-Rich Protrusions and Nonlocalized GTPase Activation in Merlin-Deficient Schwannomas , 2007, Journal of neuropathology and experimental neurology.

[21]  M. Giovannini,et al.  Merlin/neurofibromatosis type 2 suppresses growth by inhibiting the activation of Ras and Rac. , 2007, Cancer research.

[22]  George Kulik,et al.  Epidermal Growth Factor Protects Prostate Cancer Cells from Apoptosis by Inducing BAD Phosphorylation via Redundant Signaling Pathways* , 2006, Journal of Biological Chemistry.

[23]  K. Jirström,et al.  Association between Pak1 expression and subcellular localization and tamoxifen resistance in breast cancer patients. , 2006, Journal of the National Cancer Institute.

[24]  R. Kumar,et al.  PAK1 hyperactivation is sufficient for mammary gland tumor formation , 2006, Oncogene.

[25]  N. Ratner,et al.  Temporal Control of Rac in Schwann Cell–Axon Interaction Is Disrupted in NF2-Mutant Schwannoma Cells , 2006, The Journal of Neuroscience.

[26]  C. J. Barnes,et al.  P21-activated kinase 1 regulation of estrogen receptor-alpha activation involves serine 305 activation linked with serine 118 phosphorylation. , 2006, Cancer research.

[27]  J. Chernoff,et al.  Role of Group A p21-activated Kinases in Activation of Extracellular-regulated Kinase by Growth Factors* , 2005, Journal of Biological Chemistry.

[28]  L. Lim,et al.  The GIT-associated kinase PAK targets to the centrosome and regulates Aurora-A. , 2005, Molecular cell.

[29]  Jonathan A. Cooper,et al.  Src and FAK kinases cooperate to phosphorylate paxillin kinase linker, stimulate its focal adhesion localization, and regulate cell spreading and protrusiveness. , 2005, Molecular biology of the cell.

[30]  J. Field,et al.  p21-activated Kinase 1 (Pak1)-dependent Phosphorylation of Raf-1 Regulates Its Mitochondrial Localization, Phosphorylation of BAD, and Bcl-2 Association* , 2005, Journal of Biological Chemistry.

[31]  A. Hall,et al.  Cdc42 controls the polarity of the actin and microtubule cytoskeletons through two distinct signal transduction pathways , 2005, Journal of Cell Science.

[32]  Michael A Robinson,et al.  The active conformation of the PAK1 kinase domain. , 2005, Structure.

[33]  S. Jhanwar,et al.  The NF2 Tumor Suppressor Gene Product, Merlin, Inhibits Cell Proliferation and Cell Cycle Progression by Repressing Cyclin D1 Expression , 2005, Molecular and Cellular Biology.

[34]  S. Kulp,et al.  From the Cyclooxygenase-2 Inhibitor Celecoxib to a Novel Class of 3-Phosphoinositide-Dependent Protein Kinase-1 Inhibitors , 2004, Cancer Research.

[35]  A. Sahin,et al.  Dynein light chain 1, a p21-activated kinase 1-interacting substrate, promotes cancerous phenotypes. , 2004, Cancer cell.

[36]  C. J. Barnes,et al.  p21-activated Kinase-1 Signaling Mediates Cyclin D1 Expression in Mammary Epithelial and Cancer Cells* , 2004, Journal of Biological Chemistry.

[37]  J. Testa,et al.  A Clue to the Therapy of Neurofibromatosis Type 2: NF2/Merlin Is a PAK1 Inhibitor , 2004, Cancer journal.

[38]  David A. Williams,et al.  Neurofibromin-deficient Schwann cells secrete a potent migratory stimulus for Nf1+/– mast cells , 2003 .

[39]  Michael B Yaffe,et al.  Merlin, the product of the Nf2 tumor suppressor gene, is an inhibitor of the p21-activated kinase, Pak1. , 2003, Molecular cell.

[40]  J. Parsons,et al.  PAK1 phosphorylation of MEK1 regulates fibronectin-stimulated MAPK activation , 2003, The Journal of cell biology.

[41]  K. Mielke,et al.  Upregulation of the Rac1/JNK signaling pathway in primary human schwannoma cells. , 2003, Human molecular genetics.

[42]  J. Frost,et al.  Phosphorylation of Raf-1 by p21-activated Kinase 1 and Src Regulates Raf-1 Autoinhibition* , 2003, The Journal of Biological Chemistry.

[43]  Rakesh Kumar,et al.  Estrogen regulation of Pak1 and FKHR pathways in breast cancer cells , 2003, FEBS letters.

[44]  Rakesh Kumar,et al.  Emerging functions of p21‐activated kinases in human cancer cells , 2002, Journal of cellular physiology.

[45]  R. Jorissen,et al.  The K252a Derivatives, Inhibitors for the PAK/MLK Kinase Family, Selectively Block the Growth of HAS Transformants , 2002, Cancer journal.

[46]  D. Burns,et al.  Neurofibromas in NF1: Schwann Cell Origin and Role of Tumor Environment , 2002, Science.

[47]  T. Jacks,et al.  Merlin Phosphorylation by p21-activated Kinase 2 and Effects of Phosphorylation on Merlin Localization* , 2002, The Journal of Biological Chemistry.

[48]  J. Testa,et al.  p21-activated Kinase Links Rac/Cdc42 Signaling to Merlin* , 2002, The Journal of Biological Chemistry.

[49]  L. Greene,et al.  CEP-1347 (KT7515), a Semisynthetic Inhibitor of the Mixed Lineage Kinase Family* , 2001, The Journal of Biological Chemistry.

[50]  David A. Williams,et al.  Hyperactivation of P21ras and the Hematopoietic-Specific Rho Gtpase, Rac2, Cooperate to Alter the Proliferation of Neurofibromin-Deficient Mast Cells in Vivo and in Vitro , 2001, The Journal of experimental medicine.

[51]  M. Mandal,et al.  Regulatable Expression of p21-activated Kinase-1 Promotes Anchorage-independent Growth and Abnormal Organization of Mitotic Spindles in Human Epithelial Breast Cancer Cells* , 2000, The Journal of Biological Chemistry.

[52]  R. Davis,et al.  Signal Transduction by the JNK Group of MAP Kinases , 2000, Cell.

[53]  Wange Lu,et al.  Structure of PAK1 in an Autoinhibited Conformation Reveals a Multistage Activation Switch , 2000, Cell.

[54]  A. Hall,et al.  Rho GTPases and their effector proteins. , 2000, The Biochemical journal.

[55]  M. H. Cobb,et al.  Phosphatidylinositol 3-kinase regulates Raf1 through Pak phosphorylation of serine 338 , 2000, Current Biology.

[56]  M. Mandal,et al.  Regulation of Microfilament Reorganization and Invasiveness of Breast Cancer Cells by Kinase Dead p21-activated Kinase-1* , 2000, The Journal of Biological Chemistry.

[57]  John Calvin Reed,et al.  p21-Activated Kinase 1 Phosphorylates the Death Agonist Bad and Protects Cells from Apoptosis , 2000, Molecular and Cellular Biology.

[58]  F T Zenke,et al.  Identification of a Central Phosphorylation Site in p21-activated Kinase Regulating Autoinhibition and Kinase Activity* , 1999, The Journal of Biological Chemistry.

[59]  A. King,et al.  The protein kinase Pak3 positively regulates Raf-1 activity through phosphorylation of serine 338 , 1998, Nature.

[60]  J. Mendelsohn,et al.  Heregulin Regulates Cytoskeletal Reorganization and Cell Migration through the p21-activated Kinase-1 via Phosphatidylinositol-3 Kinase* , 1998, The Journal of Biological Chemistry.

[61]  J. Frost,et al.  Differential Effects of PAK1-activating Mutations Reveal Activity-dependent and -independent Effects on Cytoskeletal Regulation* , 1998, The Journal of Biological Chemistry.

[62]  L. Lim,et al.  A Conserved Negative Regulatory Region in αPAK: Inhibition of PAK Kinases Reveals Their Morphological Roles Downstream of Cdc42 and Rac1 , 1998, Molecular and Cellular Biology.

[63]  N. Neff,et al.  Motoneuron Apoptosis Is Blocked by CEP-1347 (KT 7515), a Novel Inhibitor of the JNK Signaling Pathway , 1998, The Journal of Neuroscience.

[64]  Yi Tang,et al.  Kinase-deficient Pak1 mutants inhibit Ras transformation of Rat-1 fibroblasts , 1997, Molecular and cellular biology.

[65]  N. Neff,et al.  Neurotrophic 3,9-bis[(alkylthio)methyl]-and-bis(alkoxymethyl)-K-252a derivatives. , 1997, Journal of medicinal chemistry.

[66]  S. Grinstein,et al.  Insulin Activates a p21-activated Kinase in Muscle Cells via Phosphatidylinositol 3-Kinase* , 1996, The Journal of Biological Chemistry.

[67]  C. Nobes,et al.  Rho, Rac, and Cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia , 1995, Cell.

[68]  Anne J. Ridley,et al.  The small GTP-binding protein rac regulates growth factor-induced membrane ruffling , 1992, Cell.

[69]  David A. Williams,et al.  Neurofibromin-deficient Schwann cells secrete a potent migratory stimulus for Nf1+/- mast cells. , 2003, The Journal of clinical investigation.

[70]  Maria Carla Parrini,et al.  Pak1 kinase homodimers are autoinhibited in trans and dissociated upon activation by Cdc42 and Rac1. , 2002, Molecular cell.